Try our beta test site
8 studies found for:    Lymphoma OR CLL | Chimeric Antigen Receptor-Modified T cells
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
Conditions: Leukemia;   Lymphoma
Intervention: Biological: Chimeric Antigen Receptor Modified T cells Targeting CD19
2 Recruiting Phase I/II Study of Pembrolizumab in Patients Failing to Respond to or Relapsing After Anti-CD19 Chimeric Antigen Receptor Modified T Cell Therapy for Relapsed or Refractory CD19+ Lymphomas
Conditions: CD19+ Diffuse Large B-cell Lymphomas;   Follicular Lymphomas;   Mantle Cell Lymphomas
Intervention: Drug: Pembrolizumab
3 Recruiting CART-19 Immunotherapy in Mantle Cell Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer;   Non-hodgkin Lymphoma,B Cell;   Mantle Cell Lymphoma
Intervention: Biological: anti-CD19-CAR vector-transduced T cells
4 Recruiting Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
Conditions: Leukemia, B-Cell;   Lymphoma, B-Cell
Intervention: Biological: CD19CART
5 Not yet recruiting Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Conditions: Leukemia;   Lymphoma
Intervention: Biological: Anti-CD19-CAR
6 Recruiting CART19 in Patient With ALL
Condition: Leukemia, Acute Lymphoblastic
Intervention: Biological: CART 19
7 Recruiting Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19
Conditions: Hematopoietic/Lymphoid Cancer;   Adult Acute Lymphoblastic Leukemia in Remission;   B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Chronic Lymphocytic Leukemia;   Prolymphocytic Leukemia;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma
Intervention: Biological: anti-CD19-CAR vector-transduced T cells
8 Completed CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
Conditions: Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia;   Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Mantle Cell Lymphoma;   Refractory Chronic Lymphocytic Leukemia
Intervention: Biological: allogeneic cytomegalovirus-specific cytotoxic T lymphocytes

Study has passed its completion date and status has not been verified in more than two years.